Whereas Dr. Karam's initial interests were in red blood cell transfusion thresholds, he have focused his research on bleeding and hemostasis, on thrombosis, and on Extracorporeal Membrane Oxygenation (ECMO). Over the last ten years, Dr. Karam has explored various aspects of bleeding:
He has also assessed risks of thrombotic events in children after liver transplantation and in children after red blood cell transfusions. Finally, he has studied different aspects of ECMO, from the optimal anticoagulation strategy to the indications of ECMO resuscitation
Emergency/Cardiovascular/Intensive/Pulmonary (EPIC)